Allergy unit, Deépartement de Pneumologie et Addictologie, Hôpital Arnaud-de-Villeneuve, University Hospital of Montpellier and Inserm U657, 37, avenue du Doyen Gaston Giraud, 34295, Montpellier cedex 5, France.
Clin Transl Allergy. 2012 Jun 14;2(1):10. doi: 10.1186/2045-7022-2-10.
In the general population, reports on suspected ß-lactam hypersensitivity are common. After a drug allergy work-up at best 20% of the selected patients are positive. However, these considerations have not been explored in cystic fibrosis patients for whom antibiotics are even more crucial.
The study, part of the Drug Allergy and Hypersensitivity (DAHD) cohort, was performed in the regional cystic fibrosis center of Montpellier, France. After identifying patients with a clinical history suggestive of drug allergy to ß-lactams, a complete drug allergy work-up, was carried out according to the EAACI recommendations.
Among the 171 patients involved, 23 reported clinical manifestations potentially compatible with a drug allergy to ß-lactams. After performing the complete drug-allergy work-up, 7 were considered as drug hypersensitive (3 had positive skin tests, 1 a positive provocation test, 3 declined the tests). Excluding the latter 3 patients with incomplete drug allergy work-up, the rate of proven drug allergy was 2.3%.
Drug allergy to ß-lactams in cystic fibrosis patients is of importance. A full drug allergy work-up is mandatory in case of suspicion, because ß-lactam responsibility is often ruled out.
在普通人群中,报告疑似β-内酰胺类药物过敏的情况很常见。经过药物过敏检测,只有 20%的选定患者呈阳性。然而,这些考虑因素尚未在囊性纤维化患者中进行探索,因为抗生素对囊性纤维化患者更为重要。
该研究是药物过敏和超敏反应(DAHD)队列的一部分,在法国蒙彼利埃的区域性囊性纤维化中心进行。在确定了具有疑似β-内酰胺类药物过敏临床病史的患者后,根据 EAACI 建议进行了全面的药物过敏检测。
在涉及的 171 名患者中,23 名报告了临床表现可能与β-内酰胺类药物过敏相容。在进行全面的药物过敏检测后,有 7 名被认为是药物超敏(3 名皮肤试验阳性,1 名激发试验阳性,3 名拒绝检测)。排除未进行完整药物过敏检测的后 3 名患者,明确的药物过敏率为 2.3%。
囊性纤维化患者对β-内酰胺类药物过敏很重要。怀疑时必须进行全面的药物过敏检测,因为β-内酰胺类药物的责任通常被排除在外。